Status:
COMPLETED
Diabetes Medication Choice
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
American Diabetes Association
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to examine how different ways of sharing information about diabetes medication treatment options with patients can affect their choices and health.
Eligibility Criteria
Inclusion
- Have a diagnosis of type 2 diabetes mellitus of any duration; c-peptide test not required
- Use 1 or 2 oral hypoglycemic agents; not using insulin therapy
- Are not pregnant
- Have stable but inadequate glycemic control: both A1C at the time of eligibility and previous A1c within 6 months between 7-9.5%
- Recognize their primary care provider as their main diabetes care provider
- Do not have major barriers (i.e., severe hearing impairment, dementia, cannot communicate in English) to participate in shared decision-making (per provider?s assessment)
- Have no plans to relocate out of town in the next 6 months
- Enrolment is open to males and females of diverse racial backgrounds
Exclusion
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT00388050
Start Date
July 1 2006
End Date
October 1 2008
Last Update
April 28 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905